27.65

2.37% -0.67

Evolent Health Inc (EVH)

Overview News Price History Option Chain Why EVH Down? Discussions Forecast

Evolent Health Inc stock is currently priced at $27.65, with a 24-hour trading volume of 1.04M. It has seen a -2.37% decreased in the last 24 hours and a -13.94% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $28.47 pivot point. If it approaches the $27.62 support level, significant changes may occur.

Previous Close:

$28.32

Open:

$28.36

24h Volume:

1.04M

Market Cap:

$3.15B

Revenue:

$1.96B

Net Income/Loss:

$-113.04M

P/E Ratio:

-27.11

EPS:

-1.02

Net Cash Flow:

$113.84M

1W Performance:

-6.30%

1M Performance:

-13.94%

6M Performance:

+17.01%

1Y Performance:

-21.49%

1D Range:

$27.64

$28.71

52W Range:

$23.33

$36.70

Evolent Health Inc Stock (EVH) Company Profile

Name

Evolent Health Inc

Sector

Healthcare (1191)

Industry

Health Information Services (62)

Phone

571-389-6000

Address

800 North Glebe Road, Suite 500, Arlington

Employee

2,600

Twitter

@EvolentHealth

Next Earnings Date

2024-05-15

Latest SEC Filings

EVH's Discussions on Twitter

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-24	Initiated	Barclays	Overweight
Dec-06-23	Initiated	JMP Securities	Mkt Outperform
Oct-16-23	Initiated	UBS	Buy
Apr-12-23	Initiated	Stephens	Overweight
Nov-01-22	Initiated	Truist	Hold
Jul-29-22	Initiated	RBC Capital Mkts	Outperform
Mar-30-22	Initiated	Guggenheim	Buy
Nov-18-21	Upgrade	JP Morgan	Neutral → Overweight
Apr-29-21	Resumed	JP Morgan	Neutral
Jan-07-21	Initiated	BTIG Research	Buy
Jul-06-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-05-20	Downgrade	Goldman	Buy → Neutral
Jun-02-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Oct-05-18	Resumed	Leerink Partners	Outperform
Jun-04-18	Initiated	Piper Jaffray	Overweight
Apr-24-18	Resumed	JP Morgan	Neutral
Sep-20-17	Initiated	KeyBanc Capital Mkts	Overweight
Jun-02-17	Initiated	Robert W. Baird	Outperform
Mar-14-17	Initiated	Oppenheimer	Outperform
Jan-13-17	Upgrade	Wells Fargo	Market Perform → Outperform
Oct-28-16	Resumed	JP Morgan	Overweight
Aug-05-16	Reiterated	FBR Capital	Outperform
Jul-26-16	Initiated	Jefferies	Buy
Jul-13-16	Reiterated	FBR Capital	Outperform
Mar-29-16	Initiated	FBR Capital	Outperform
Jan-06-16	Initiated	Canaccord Genuity	Buy
Jun-30-15	Initiated	Goldman	Buy
Jun-30-15	Initiated	JP Morgan	Overweight
Jun-30-15	Initiated	Leerink Partners	Outperform
Jun-30-15	Initiated	Sun Trust Rbsn Humphrey	Buy

View All

Evolent Health Inc Stock (EVH) Latest News

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health

Benzinga

Navigating 4 Analyst Ratings For Evolent Health

Benzinga

Does Evolent Health (EVH) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?

Zacks Investment Research

Wall Street Analysts Predict a 35.7% Upside in Evolent Health (EVH): Here's What You Should Know

Zacks Investment Research

These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results

Benzinga

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Evolent Health Inc Stock (EVH) Financials Data

Evolent Health Inc (EVH) Revenue 2024

EVH reported a revenue (TTM) of $1.96 billion for the quarter ending December 31, 2023, a +45.26% rise year-over-year.

Evolent Health Inc (EVH) Net Income 2024

EVH net income (TTM) was -$113.04 million for the quarter ending December 31, 2023, a -489.86% decrease year-over-year.

Evolent Health Inc (EVH) Cash Flow 2024

EVH recorded a free cash flow (TTM) of $113.84 million for the quarter ending December 31, 2023, a +328.07% increase year-over-year.

Evolent Health Inc (EVH) Earnings per Share 2024

EVH earnings per share (TTM) was -$1.27 for the quarter ending December 31, 2023, a -535.00% decline year-over-year.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.